XENE Xenon Pharmaceuticals Inc.

3.90
+0  (5%)
Previous Close 3.70
Open 3.75
Price To book 1.04
Market Cap 69.95M
Shares 17,935,000
Volume 59,583
Short Ratio 1.75
Av. Daily Volume 158,406

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 data released March 24, 2017 - endpoints not met.
XEN801
Acne
Phase 2b initiated late March 2015. Data due mid-2017.
TV-45070
Postherpetic neuralgia
Phase 2b trial did not meet endpoints - July 2015
TV-45070
Osteoarthritis